VTE and Cancer VTE Prophylaxis in the Cancer Patient Scope, Trials, Guidelines and Solutions VTE Prophylaxis in the Cancer Patient Scope, Trials, Guidelines.
An audit of the antithrombotic therapy for the management of valve repair or replacement Gellatly RM 1,2, Maydelmin D 1, Connell C 1, Marasco S 3, Zimmet.
Low Molecular Weight Heparin as bridging anticoagulant early after mechanical heart valve replacement. P Meurin, JY Tabet, A Ben Driss, H Weber, N Renaud.
EMORRAGIA COAGULAZIONE TROMBOSI LEMERGENZA E OLTRE Mantova 17 Aprile 2010 Ricoagulare il paziente scoagulato farmacologicamente Franco Manzato.
Nuevos antitromboticos
The Perioperative Management of Anti Thrombotic Therapy - American College of Chest Physicians Evidence-Based Clinical Practice Guidelines - 8th Edition
Deep Vein Thrombosis Prophylaxis in Trauma Patients
Reversal of TSOACs 1 st Qatar Conference on Safe Anticoagulation Management (QCSAM): New Advances and Trends 28 February 2015 Scott Kaatz, DO, MSc, FACP,
Optimizing Management of Pulmonary Embolism: From Threat to Therapy Samuel Z. Goldhaber, MD Cardiovascular Division Brigham and Women’s Hospital Professor.
C ANCER -A SSOCIATED T HROMBOSIS : W HAT YOU NEED TO KNOW Anne McLeod.
Chapter Eleven Venous Disease Coalition Chronic Venous Insufficiency VTE Toolkit.
Optimal Strategies for DVT Prophylaxis: Translating Evidence into Practice Samuel Z. Goldhaber, MD Cardiovascular Division Brigham and Women’s Hospital.
